Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Patent Application Describes HemogloBind™ To Reduce Analytical Interferences from HemolysisBy: Biotech Support Group Krishna, Neel K., and Kenji Cunnion. "Derivative Peptide Compounds and Methods of Use." U.S. Patent Application No. 15/192,934. http://www.freepatentsonline.com/ The patent application describes synthetic peptide compounds for therapy and diagnostics of complement-mediated diseases, such as inflammatory diseases, autoimmune diseases, and microbial and bacterial infections and non-complement- "The large amount of hemoglobin in samples of this type presents a special challenge for quantitative analysis. These articles demonstrate yet again that HemogloBind™ Click here for more information on HemogloBind™ Click here for more information on all of our Hemoglobin Removal products (https://www.biotechsupportgroup.com/ About Biotech Support Group LLC Converging with cultural and technological disruptions forthcoming in healthcare, Biotech Support Group develops methods for cost effective and efficient sample prep essential for these expanding markets. Following a tiered business strategy, the company continues its growth in the consumable research products area supporting the rapidly expanding installation of LC-MS instrument and computational infrastructure. For this market, key products include: AlbuVoid™ and AlbuSorb™ for albumin depletion, Cleanascite™ Contact: Matthew Kuruc 732-274-2866 mkuruc@biotechsupportgroup.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|